SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-044713
Filing Date
2022-04-11
Accepted
2022-04-11 17:00:56
Documents
1
Period of Report
2022-04-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2212468d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2212468d2_4.xml 4 4095
  Complete submission text file 0001104659-22-044713.txt   5469
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 U.S. 9 SUITE 500 MANALAPAN TOWNSHIP NJ 07726
Business Address
Bradley Greg (Reporting) CIK: 0001833504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 22820245